http://www.reportlinker.com/ci02266/Therapy.html Fri, 24 May 2013 09:31:39 +0000 helpdesk@reportlinker.com Copyright 2013, Reportlinker Zend_Feed en-us http://blogs.law.harvard.edu/tech/rss http://www.reportlinker.com/d014351843/Company-Report-Therapy-in-Austria-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014351843/Company-Report-Therapy-in-Austria-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Austron | march 2013 4 the therapy provided by medaustron medaustron will provide an innovative form of radiation therapy, namely ion beam therapy. In that process the tumours are irradiated with charged ...]]> Thu, 28 Feb 2013 23:00:00 +0000 http://www.reportlinker.com/d014226599/Kelly-Geren-and-Searcy-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014226599/Kelly-Geren-and-Searcy-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ]]> Mon, 31 Dec 2012 23:00:00 +0000 http://www.reportlinker.com/d014191478/Pain-Therapeutics-Inc-Investment-Analysis-December-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014191478/Pain-Therapeutics-Inc-Investment-Analysis-December-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... And oxymorphone, are reimbursed by pfizer. A71 pain therapeutics retains commercial rights to remoxy and three other abuse-resistant drug cands in australia/new zealand. We have not yet announced a market ...]]> Fri, 30 Nov 2012 23:00:00 +0000 http://www.reportlinker.com/d014318890/Company-Report-Therapeutics-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014318890/Company-Report-Therapeutics-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... On applying gene therapy technology to genetically modify a patient S own t-cells, known as chimeric antigen receptor (car) t-cells, to target and destroy cancer cells. Celgene has an option to license any ...]]> Tue, 30 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/d014328714/Company-Report-Hydrotherapy-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014328714/Company-Report-Hydrotherapy-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... To develop ideas and evaluate options for the provision of water based exercise and hydrotherapy as a rehabilitation treatment modality across the scottish borders and to seek approval to move forward ...]]> Thu, 28 Feb 2013 23:00:00 +0000 http://www.reportlinker.com/d014260141/Company-Report-Therapy-in-Ireland-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014260141/Company-Report-Therapy-in-Ireland-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... As a therapist, teacher and supervisor, eoin is president of pci college, and a director of cbt solutions therapy practice in clondalkin. He has particular interest in issues such as sexual addiction and social ...]]> Thu, 28 Feb 2013 23:00:00 +0000 http://www.reportlinker.com/d014350532/Company-Report-Drug-Therapy-in-Poland-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014350532/Company-Report-Drug-Therapy-in-Poland-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Of the costs of drug therapy to health systems and society towsend 1986 pharmacoeconomics Research that identifies, measures and compares the costs (resources consumed) and the economic, clinical ...]]> Tue, 30 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/d014332077/Therapeutics-Industry-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014332077/Therapeutics-Industry-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Private donations Philanthropic organizations Patient advocacy groups 45 disease-focused groups step in: selected grants philanthropy company als biopharma, yuma therapeutics, metabolic solutions ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014100049/World-Liver-Diseases-Therapeutics-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014100049/World-Liver-Diseases-Therapeutics-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Portfolio and recent developments is also provided in the report. Transparency market research liver diseases therapeutics market - global industry analysis, size, share, trends ...]]> Mon, 31 Dec 2012 23:00:00 +0000 http://www.reportlinker.com/d014097746/U-S-Therapy-Business-Brief-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014097746/U-S-Therapy-Business-Brief-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... At the right time) So why is a statistician talking to you about personalized medicine My goal: t o con vince y ou that the quantitativ e sciences , and especially statistics , are essential ...]]> Mon, 31 Dec 2012 23:00:00 +0000 http://www.reportlinker.com/p01182934/OpportunityAnalyzer-Idiopathic-Pulmonary-Fibrosis-IPF-Opportunity-Analysis-and-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01182934/OpportunityAnalyzer-Idiopathic-Pulmonary-Fibrosis-IPF-Opportunity-Analysis-and-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia ...]]> Mon, 29 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p0284904/Analytical-Tool-Protein-Kinase-Inhibitors-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p0284904/Analytical-Tool-Protein-Kinase-Inhibitors-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors ...]]> Sun, 21 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p0768122/Personalized-Medicine-Partnering-Terms-and-Agreements.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p0768122/Personalized-Medicine-Partnering-Terms-and-Agreements.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine Partnering ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/p01138839/Peptide-Therapeutics-Market-Global-Industry-Analysis-Size-Share-Growth-Trends-And-Forecast.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01138839/Peptide-Therapeutics-Market-Global-Industry-Analysis-Size-Share-Growth-Trends-And-Forecast.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are ...]]> Tue, 12 Mar 2013 23:00:00 +0000 http://www.reportlinker.com/p01160237/Oncology-Therapeutics-Market-in-India-to-Introduction-of-Market-Based-Pricing-to-Fuel-Price-Wars-and-Intense-Competition-Among-Domestic-and-Multinational-Players.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01160237/Oncology-Therapeutics-Market-in-India-to-Introduction-of-Market-Based-Pricing-to-Fuel-Price-Wars-and-Intense-Competition-Among-Domestic-and-Multinational-Players.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Summary GBI Research, the leading ...]]> Sun, 07 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p01165130/Global-Cardiac-Resynchronization-Therapy-CRT-Devices-Market-Growth-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01165130/Global-Cardiac-Resynchronization-Therapy-CRT-Devices-Market-Growth-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Global Market Watch: The broad ?health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac ...]]> Sun, 14 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p01159680/Clinical-Stage-Partnering-Terms-and-Agreements-in-Pharma-and-Biotech.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01159680/Clinical-Stage-Partnering-Terms-and-Agreements-in-Pharma-and-Biotech.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered ...]]> Sun, 31 Mar 2013 22:00:00 +0000